dc.contributor.author | Mayerhofer, Christiane Caroline | |
dc.contributor.author | Ueland, Thor | |
dc.contributor.author | Broch, Kaspar | |
dc.contributor.author | Vincent, Royce P. | |
dc.contributor.author | Cross, Gemma F. | |
dc.contributor.author | Dahl, Christen Peder | |
dc.contributor.author | Aukrust, Pål | |
dc.contributor.author | Gullestad, Lars | |
dc.contributor.author | Hov, Johannes Espolin Roksund | |
dc.contributor.author | Trøseid, Marius | |
dc.date.accessioned | 2018-07-04T08:04:00Z | |
dc.date.available | 2018-07-04T08:04:00Z | |
dc.date.issued | 2017-09-09 | |
dc.description.abstract | <p><i>Objective</i>
Bile acids (BAs) are now recognized as signaling molecules and emerging evidence suggests that BAs affect cardiovascular function. The gut microbiota has recently been linked to the severity of heart failure (HF), and microbial metabolism has a major impact on BA homeostasis. We aimed to investigate the pattern of BAs, and particularly microbiota-transformed (secondary) BAs, in patients with chronic HF.</p>
<p><i>Methods and Results</i>
This was a prospective, observational, single-center study including 142 patients with chronic HF and 20 age- and sex-matched healthy control subjects. We measured plasma levels of primary, secondary, and total BAs, and explored their associations with clinical characteristics and survival. Plasma levels of primary BAs were lower (P < .01) and the ratios of secondary to primary BAs higher (P < .001) in patients with HF compared with control subjects. Approximately 40% of patients in the upper tertile of the ratio of secondary to primary BAs died during 5.6 years of follow-up (unadjusted Cox regression: hazard ratio 1.93, 95% confidence interval 1.01–3.68, compared with the lower tertiles). However, this association was attenuated and no longer significant in multivariate analyses.</p>
<p><i>Conclusions</i>
Levels of primary BAs were reduced and specific secondary BAs increased in patients with chronic HF. This pattern was associated with reduced overall survival in univariate analysis, but not in multivariate analyses. Future studies should assess the regulation and potential role of BA metabolism in HF. | en_US |
dc.description.sponsorship | Norwegian Health Association (6782) | en_US |
dc.description | Accepted manuscript version. Published version available at <a href=https://doi.org/10.1016/j.cardfail.2017.06.007> https://doi.org/10.1016/j.cardfail.2017.06.007</a>. | en_US |
dc.identifier.citation | Mayerhofer, C.C., Ueland, T., Broch, K., Vincent, R.P., Cross, G.F., ... Trøseid, M. (2017). Increased secondary/primary bile acid ratio in chronic heart failure. Journal of Cardiac Failure, 23(9), 666-671. https://doi.org/10.1016/j.cardfail.2017.06.007 | en_US |
dc.identifier.cristinID | FRIDAID 1514342 | |
dc.identifier.doi | 10.1016/j.cardfail.2017.06.007 | |
dc.identifier.issn | 1071-9164 | |
dc.identifier.issn | 1532-8414 | |
dc.identifier.uri | https://hdl.handle.net/10037/13143 | |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.journal | Journal of Cardiac Failure | |
dc.relation.projectID | info:eu-repo/grantAgreement/RCN/FRIMEDBIO/240787/Norway/NORGUT: EXPLORING THE METABOLIC SIGNATURES OF DISEASE AND DRUG ASSOCIATED GENOMIC FEATURES OF THE GUT MICROBIOTA IN NORWAY// | en_US |
dc.rights.accessRights | openAccess | en_US |
dc.subject | VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750 | en_US |
dc.subject | VDP::Medical disciplines: 700::Clinical medical disciplines: 750 | en_US |
dc.subject | Chronic heart failure | en_US |
dc.subject | gut microbiota | en_US |
dc.subject | Bile acids profile | en_US |
dc.subject | clinical outcome | en_US |
dc.title | Increased secondary/primary bile acid ratio in chronic heart failure | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |